This guide is a companion to our complete diagnosis guide . It explains one decision that is easy to miss and impossible to undo later: what happens to your tumor tissue.
An OncoGuide note, added to the FCCT guide below — the one thing we most wish we had understood at the first biopsy. Tissue is finite, it is not renewable, and — this is the part that surprises people — a good response to treatment can quietly close the door on ever getting more. Plan for the whole journey, not just the first diagnosis.
Over the course of treatment, one small biopsy may be asked to serve several separate needs, each of which consumes material:
- the first molecular test (comprehensive DNA/RNA sequencing, “NGS”) that chooses your first-line therapy;
- often a second molecular test at resistance, if the cancer changes and a new driver has to be found — that is at least two full sequencing runs before anything else;
- a tumor-informed blood test for recurrence (MRD), built from a one-time tumor sequencing;
- and, if you ever pursue one, a personalized (neoantigen) cancer vaccine — which typically needs substantially more material than a routine panel, because it may require whole-exome and whole-transcriptome sequencing, and several centers strongly prefer fresh-frozen tissue over paraffin.
A standard core biopsy is often just enough for the first diagnosis and little more. So at the first procedure — while there is still tumor to sample — it is worth asking, in writing, for extra cores, asking whether a portion can be kept fresh-frozen (not only fixed in paraffin), and making sure the diagnostic block is not completely used up by the first test.
Why the timing is unforgiving: if treatment works very well, there may later be no biopsiable tumor left — nothing active or large enough to sample safely. That is a good problem to have. But it means the tissue you banked early may be the only tissue you will ever have — and a paraffin block that seemed adequate can turn out to hold less than a millimetre of usable tumour when a vaccine lab finally measures it. Ask for a written inventory of what remains after each test, so you are never surprised late.
If a vaccine is on your mind, we wrote a companion piece on exactly this: Personalized cancer vaccines, part 2 — the tissue you need, and why to secure it early .
Why this matters
Tumor tissue is one of the most valuable clinical resources in cancer care. It can be used for diagnosis, molecular testing, treatment planning, clinical trial matching, and, in some cases, more advanced personalized approaches.
Tissue is usually collected during a biopsy or surgery, usually for diagnostic purposes. But by the time you later need additional testing, drug-response work, immune profiling, or future re-analysis, the best opportunity to preserve tissue may have passed.
The landscape of cancer diagnostics is evolving rapidly. Current applications for tumor tissue include comprehensive DNA and RNA sequencing, protein staining, immune profiling, spatial biology, and drug-response testing. Preserved tissue allows for future re-analysis as new biomarkers, therapies, and testing methods emerge.
Pursuing high-quality preservation does not mean you need to commit to a specific treatment path. It simply keeps more clinical options open for the future.
What tumor tissue can be used for
A single well-preserved sample can support many different tests:
- Molecular profiling: DNA and RNA sequencing to identify mutations, gene expression patterns, and potentially actionable biomarkers.
- Pathology staining: Protein and biomarker testing used to classify tumors and guide therapy selection.
- Drug response testing: Testing live tumor cells against therapies in a laboratory setting. This requires fresh tissue processed quickly after collection.
- Immune profiling: Characterizing immune cells within the tumor microenvironment to inform immunotherapy approaches.
- Personalized therapy development: Supporting neoantigen vaccine design, engineered cell therapies, and other individualized approaches.
What happens to tissue by default
When tissue is removed during a biopsy or surgery, it goes to the hospital’s pathology department. Part is used for diagnosis, and the remainder is typically chemically fixed, embedded in paraffin wax, and archived for future clinical use.
This standard process works well for diagnosis and later sequencing, but it has limitations:
- Fixed tissue cannot be used for tests that need living cells.
- Storage policies vary, though institutions commonly retain blocks under College of American Pathologists (CAP) and other regulatory standards.
- Tissue stays at the institution that collected it, and sending it elsewhere later can take time.
Before a biopsy or surgery
Raise it early
As soon as a procedure is scheduled, tell your care team you would like to talk about tissue preservation.
Ask about extra tissue
Sometimes the team can collect more than the minimum needed for diagnosis. It depends on the procedure and should be discussed with your surgeon and pathologist.
Ask about fresh or frozen tissue
Some downstream applications, such as drug-response testing or immune analyses, require a portion to be preserved fresh or frozen rather than only fixed in chemicals. This has to be arranged in advance.
Consider a tissue preservation service
Several organizations specialize in preserving a patient’s tumor at the time of biopsy or surgery, including living tissue for future use. They coordinate with the hospital and store the tissue under your control. Arranging this takes lead time.
If tissue has already been collected
If a procedure has already happened, options are more limited, but several steps are still useful:
- Find out what exists: Ask where the tissue is stored, in what form, how much remains, and how long it will be retained.
- Request your blocks or slides if needed: Pathology materials can often be transferred to another institution or testing laboratory, though the process may take time.
- Use archived tissue for additional testing: Existing samples can often be used for additional sequencing or biomarker analysis.
- Plan for future procedures: If another biopsy or surgery is likely, use it as an opportunity for more comprehensive preservation.
One important point: a tumor removed years ago may be genetically different from the cancer as it exists today, especially after treatment. While studies suggest most of the genetic alterations are similar between primary and recurrent cancers, a fresh sample is sometimes valuable even when older tissue is available. Whether you need new tissue is a question for your care team.
Questions to ask your care team
Pick the questions most relevant to your situation, and use these as conversation starters.
- What happens to my tissue after this procedure?
- Can additional tissue be collected beyond what is needed for diagnosis?
- Can a portion be preserved fresh or frozen, not only fixed in chemicals?
- How much tissue is likely to remain after diagnosis, and how long will it be stored?
- If I want to use a tissue preservation service, can the team coordinate with them?
- Given my diagnosis, what tests might this tissue be useful for, now or later?
Final note
Preserving tumor tissue allows for the ability to pursue future molecular analysis, research participation, or emerging therapeutic approaches as cancer care continues to evolve. External storage or vendor services are often an out-of-pocket cost and may not be insurance-covered.
The most important step is to start the conversation early. Ask your care team what tissue will be collected, how it will be preserved, where it will be stored, and how long it will remain available. Having that information can help keep future diagnostic, research, and treatment options open as cancer care and testing technologies continue to evolve.
- If a biopsy or surgery is scheduled, raise tissue preservation now – before the procedure, not after.
- Ask whether extra tissue can be collected beyond what diagnosis needs, and whether a portion can be kept fresh or frozen.
- Ask where your tissue will be stored and for how long.
- If a procedure already happened, ask what tissue still exists and whether it can be used or transferred to another lab.
- Read the original FCCT guide and bring the questions above to your care team.